192 related articles for article (PubMed ID: 34562122)
1. COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center.
Oderda M; Soria F; Rosi F; Calleris G; Mazzoli S; Giordano A; Pizzuto G; Marquis A; De Bellis M; Vitiello F; Vercelli E; Peretti F; Montefusco G; Gontero P
World J Urol; 2022 Jan; 40(1):263-269. PubMed ID: 34562122
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres.
Campi R; Amparore D; Capitanio U; Checcucci E; Salonia A; Fiori C; Minervini A; Briganti A; Carini M; Montorsi F; Serni S; Porpiglia F
Eur Urol; 2020 Jul; 78(1):11-15. PubMed ID: 32307215
[TBL] [Abstract][Full Text] [Related]
3. How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.
Oderda M; Calleris G; Falcone M; Fasolis G; Muto G; Oderda G; Porpiglia F; Volpe A; Bertetto O; Gontero P
Urologia; 2021 Feb; 88(1):3-8. PubMed ID: 33632087
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.
Taheri D; Jahanshahi F; Khajavi A; Kafi F; Pouramini A; Farsani RM; Alizadeh Y; Akbarzadeh M; Reis LO; Khatami F; Aghamir SMK
Clin Genitourin Cancer; 2023 Feb; 21(1):84-90. PubMed ID: 36517394
[TBL] [Abstract][Full Text] [Related]
5. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; Rouprêt M
World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
[TBL] [Abstract][Full Text] [Related]
6. Management of urologic cancers during the pandemic and potential impact of treatment deferrals on outcomes.
Mian BM; Siddiqui S; Ahmad AE
Urol Oncol; 2021 May; 39(5):258-267. PubMed ID: 33129674
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 pandemic on prostate cancer outcomes at an uro-oncology referral center.
Andrade GM; Sesconetto L; da Silva RBR; Dos Santos GGR; Kayano PP; Baccaglini W; Bezerra MB; Bianco B; Lemos GC; Carneiro A
Int Braz J Urol; 2023; 49(2):233-242. PubMed ID: 36826377
[TBL] [Abstract][Full Text] [Related]
8. How Does the COVID-19 Pandemic Influence Histopathological Outcomes for Urologic Cancers?
Kalemci S; Ergun KE; Akyol A; Kizilay F
Cureus; 2022 Jul; 14(7):e26500. PubMed ID: 35923484
[TBL] [Abstract][Full Text] [Related]
9. Bladder recurrence after radical nephroureterectomy: predictors and impact on oncological outcomes.
Elalouf V; Xylinas E; Klap J; Pignot G; Delongchamps NB; Saighi D; Peyromaure M; Flam T; Zerbib M
Int J Urol; 2013 Nov; 20(11):1078-83. PubMed ID: 23521657
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.
Li Q; Assel M; Benfante N; Pietzak E; Bagrodia A; Cha E; Dalbagni G; Coleman J
J Urol; 2017 Sep; 198(3):546-551. PubMed ID: 28342936
[TBL] [Abstract][Full Text] [Related]
11. Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.
Briganti A; Bianchi M; Sun M; Suardi N; Gallina A; Abdollah F; Bertini R; Colombo R; Girolamo VD; Salonia A; Scattoni V; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 Jun; 111(8):1222-30. PubMed ID: 23145532
[TBL] [Abstract][Full Text] [Related]
12. Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.
Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Peltier A; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Quackels T; Roumeguère T; Albisinni S
World J Urol; 2021 Jun; 39(6):1789-1796. PubMed ID: 32776243
[TBL] [Abstract][Full Text] [Related]
13. Impact of COVID-19 Pandemic on Health-Related Quality of Life in Uro-oncologic Patients: What Should We Wait For?
Greco F; Altieri VM; Esperto F; Mirone V; Scarpa RM
Clin Genitourin Cancer; 2021 Apr; 19(2):e63-e68. PubMed ID: 32863188
[TBL] [Abstract][Full Text] [Related]
14. Robot-assisted versus open radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: A retrospective cohort study across ten years.
Zeuschner P; Vollmer SG; Linxweiler J; Wagenpfeil G; Wagenpfeil S; Saar M; Siemer S; Stöckle M; Heinzelbecker J
Surg Oncol; 2021 Sep; 38():101607. PubMed ID: 34022505
[TBL] [Abstract][Full Text] [Related]
15. Urologic cancer in China.
Pang C; Guan Y; Li H; Chen W; Zhu G
Jpn J Clin Oncol; 2016 Jun; 46(6):497-501. PubMed ID: 27049022
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.
Murakami Y; Matsumoto K; Ikeda M; Utsunomiya T; Hirayama T; Koguchi D; Matsuda D; Okuno N; Taoka Y; Irie A; Iwamura M
Asia Pac J Clin Oncol; 2018 Aug; 14(4):310-317. PubMed ID: 29356359
[TBL] [Abstract][Full Text] [Related]
17. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
[TBL] [Abstract][Full Text] [Related]
18. Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic.
Dotzauer R; Böhm K; Brandt MP; Sparwasser P; Haack M; Frees SK; Kamal MM; Mager R; Jäger W; Höfner T; Tsaur I; Haferkamp A; Borgmann H
World J Urol; 2021 Sep; 39(9):3139-3145. PubMed ID: 32623500
[TBL] [Abstract][Full Text] [Related]
19. Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic.
Ginsburg KB; Curtis GL; Timar RE; George AK; Cher ML
J Urol; 2020 Oct; 204(4):720-725. PubMed ID: 32356508
[TBL] [Abstract][Full Text] [Related]
20. Effect of body mass index on the outcomes of patients with upper and lower urinary tract cancers treated by radical surgery: results from a Canadian multicenter collaboration.
Bachir BG; Aprikian AG; Izawa JI; Chin JL; Fradet Y; Fairey A; Estey E; Jacobsen N; Rendon R; Cagiannos I; Lacombe L; Lattouf JB; Kapoor A; Matsumoto E; Saad F; Bell D; Black PC; So AI; Drachenberg D; Kassouf W
Urol Oncol; 2014 May; 32(4):441-8. PubMed ID: 24412632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
